Wells Fargo Initiates Coverage On HealthEquity with Overweight Rating, Announces Price Target of $95
Wells Fargo analyst Stan Berenshteyn initiates coverage on HealthEquity (NASDAQ:HQY) with a Overweight rating and announces Price Target of $95.
Guggenheim Initiates Coverage On HealthEquity with Buy Rating, Announces Price Target of $89
Guggenheim analyst Sandy Draper initiates coverage on HealthEquity (NASDAQ:HQY) with a Buy rating and announces Price Target of $89.
Where HealthEquity Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on HealthEquity (NASDAQ:HQY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Jefferies Maintains Buy on HealthEquity, Raises Price Target to $80
Jefferies analyst Glen Santangelo maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $62 to $80.
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $66
Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $62 to $66.
Recap: HealthEquity Q4 Earnings
HealthEquity (NASDAQ:HQY) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
CNBC’s Final Trades: HealthEquity, Carlyle, Cameco, Citigroup And This Retailer
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said HealthEquity Inc’s (NASDAQ: HQY) stock had “a terrible year” in 2021.
All The Stocks That Moved From CNBC’s ‘Fast Money: Halftime Report’
CNBC’s "Fast Money: Halftime Report" delivers market moving news to investors.